DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS (Q2035310): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
description / en | description / en | ||
Project in Italy | Project Q2035310 in Italy | ||
description / it | description / it | ||
Progetto in Italia | Progetto Q2035310 in Italia |
Revision as of 08:41, 2 November 2020
Project Q2035310 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS |
Project Q2035310 in Italy |
Statements
183,393.18 Euro
0 references
366,786.35 Euro
0 references
50.0 percent
0 references
13 December 2016
0 references
6 July 2019
0 references
UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
0 references
KAY SYSTEMS ITALIA SRL
0 references
LA RADIOTERAPIA MOLECOLARE, INDICATA IN MOLTE NEOPLASIE, IMPIEGA RADIONUCLIDI COME SORGENTI NON SIGILLATE (SPESSO RADIOFARMACI) PER RILASCIARE RADIAZIONI E DISTRUGGERE CELLULE NEOPLASTICHE. (Italian)
0 references
THE MOLECULAR RADIOTHERAPY, REFERRED TO IN MANY CANCERS, USES RADIONUCLIDES AS NON-SEALED SOURCES (OFTEN RADIOPHARMACEUTICALS) TO RELEASE RADIATION AND DESTROY NEOPLASTIC CELLS. (English)
0 references
Identifiers
F87H18000440007
0 references